References
- Abbott, A. (1988). The system of professions: An essay on the division of expert labor. Chicago, IL: University of Chicago Press.
- Beck, U. (1992). Risk society: Towards a new modernity. Thousand Oaks, CA: Sage.
- Brown, P. (2006). Risk versus need in revising the 1983 Mental Health Act: Conflicting claims, muddled policy. Health, Risk & Society, 8(4), 343–358. doi:10.1080/13698570601008248
- Campbell, B., & Patrick, H. (2012). International collaboration in the use of registries for new devices and procedures. British Journal of Surgery, 99, 744–745. doi:10.1002/bjs.8791
- Cavazos, V. (2012). Mesh misery update: Tucson doctors defend the use of surgical mesh. Retrieved from http://www.jrn.com/kgun9/news/164235896.html
- Conrad, P. (2005). The shifting engines of medicalisation. Journal of Health and Social Behavior, 46, 3–14. doi:10.1177/002214650504600102
- Conrad, P. (2007). The medicalisation of society: On the transformation of human conditionsinto treatable disorders. Baltimore, MD: Johns Hopkins University Press.
- Conrad, P., & Schneider, J. W. (1992). Deviance and medicalisation: From badness to sickness. Philadelphia, PA: Temple University Press.
- Davidoff, F. (2006). Sex, politics and morality at the FDA: Reflections on the Plan B decision. Hastings Center Report, 36, 20–25. doi:10.1353/hcr.2006.0021
- Davis, C., & Abraham, J. (2011). A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation. Health, Risk & Society, 13, 413–431. doi:10.1080/13698575.2011.596191
- Edge, S., & Eyles, J. (2013). Message in a bottle: Claims disputes and the reconciliation of precaution and weight-of-evidence in the regulation of risks from Bisphenol A in Canada. Health, Risk & Society, 15(5), 432–448. doi:10.1080/13698575.2013.802293
- Faulkner, A. (2009). Medical technology into healthcare and society. London: Palgrave Macmillan.
- Faulkner, A., & Kent, J. (2001). Innovation and regulation in human implant technologies: Developing comparative approaches. Social Science & Medicine, 53, 895–913. doi:10.1016/S0277-9536(00)00389-0
- Food and Drug Administration. (2008). FDA safety communication: Surgical mesh. Retrieved from http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm142636.htm
- Food and Drug Administration (2011a, September 8–9). Obstetrics and gynecology devices panel of the medical devices advisory committee meeting announcement. FDA. Retrieved June 30, from http://www.fda.gov/AdvisoryCommittees/Calendar/ucm262495.htm
- Food and Drug Administration. (2011b). FDA safety communication: Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. FDA. Retrieved July 13, from http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm
- Food and Drug Administration. (2011c). Urogynecological surgical mesh: Update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. Retrieved from http://www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf
- Food and Drug Administration. (2011d). Obstetrics and Gynecology Medical Devices Panel of the Center for Devices and Radiological Health Medical Devices Advisory Committee. Retrieved from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM275043.pdf
- Food and Drug Administration. (2011e). Obstetrics and gynecology medical devices panel of the center for devices and radiological health medical devices advisory committee. Retrieved from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM275061.pdf
- Food and Drug Administration. (2011f). Obstetrics & Gynecology Devices Panel. Retrieved September 8–9, from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM271769.pdf
- Food and Drug Administration. (2013). Medical devices: Pelvic organ prolapse. Retrieved from http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm262299.htm
- Friedson, E. (1988). The profession of medicine: A study of the sociology of applied knowledge. Chicago, IL: University of Chicago Press.
- Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: Strategies for qualitative research. Chicago, IL: Aldine Publishing Company.
- Jasanoff, S. S. (1987). Contested boundaries in policy-relevant science. Social Studies of Science, 17, 195–230. doi:10.1177/030631287017002001
- Kent, J., & Faulkner, A. (2002). Regulating human implant technologies in Europe—Understanding the new era in medical device regulation. Health, Risk & Society, 4, 189–209. doi:10.1080/13698570220137060
- Kewell, B. J. (2006). Language games and tragedy: The Bristol Royal infirmary disaster revisited. Health Risk and Society, 8, 359–377. doi:10.1080/13698570601008305
- Kinchen., K. S., Burgio, K., Diokno, A. C., Fultz, N. H., Bump, R., & Obenchain, R. (2003). Factors associated with women’s decisions to seek treatment for urinary incontinence. Journal of Women’s Health, 12, 687–698. doi:10.1089/154099903322404339
- Kinchen, K. S., Lee, J., Fireman, B., Hunkeler, E., Nehemiah, J. L., & Curtice, T. G. (2007). The prevalence,burden and treatment of urinary incontinence among women in a managed care plan. Journal of Women’s Health, 16, 415–422. doi:10.1089/jwh.2006.0122
- Lindblom, C. (1959). The science of ‘muddling through’. Public Administration Review, 19, 79–88. doi:10.2307/973677
- Lindblom, C. (1979). Still muddling, not yet through. Public Administration Review, 39, 517–526. doi:10.2307/976178
- Lupton, D. (1993). Risk as moral danger: The social and political functions of risk discourse in public health. International Journal of Health Services, 23(3), 425–435. doi:10.2190/16AY-E2GC-DFLD-51X2
- MarketWatch, PR Newswire. (2014). Transvaginal mesh lawsuit settlement news: Mass tort services expect more mesh settlements by end of year. Retrieved from http://www.marketwatch.com/story/transvaginal-mesh-lawsuit-settlement-news-mass-tort-services-expect-more-mesh-settlements-by-end-of-year-2014-10-07
- Markey, Edward, Congressman. (2012). Markey, Waxman, Schakowsky, DeLauro introduce legislation to close loophole in flawed medical device approval process. Retrieved from http://markey.house.gov/press-release/markey-waxman-schakowsky-delauro-introduce-legislation-close-loophole-flawed-medical
- Mauws, M. K., & Phillips, N. (1995). Crossroads understanding language games. Organization Science, 6(3), 322–334. doi:10.1287/orsc.6.3.322
- McDonald, R., Waring, J., & Harrison, S. (2005). ‘Balancing risk, that is my life’: The politics of risk in a hospital operating theatre department. Health, Risk & Society, 7(4), 397–411. doi:10.1080/13698570500390705
- Melville., J. L., Katon, W., Delaney, K., & Newton, K. (2005). Urinary incontinence in US women. Archives of Internal Medicine, 165, 537–542. doi:10.1001/archinte.165.5.537
- Mills, C. W. (1959). The sociological imagination. New York, NY: Oxford University Press.
- National Institutes of Health. (2013). Stress incontinence. Retrieved from http://www.nlm.nih.gov/medlineplus/ency/article/000891.htm
- Public Citizen. (2011). Petition to ban surgical mesh for transvaginal repair of pelvic organ prolapse. Retrieved from http://www.citizen.org/petition-to-fda-to-ban-surgical-mesh-for-transvaginal-repair-of-pelvic-organ-prolapse
- Spector, M., & Kitsuse, J. I. (1977). Constructing social problems. Menlo Park: The Benjamin/Cummings Publishing Company.
- Starr, P. (1984). The social transformation of American medicine: The rise of a sovereign profession and the making of a vast industry. New York, NY: Basic Books.
- Teston, C., Graham, S., Baldwinson, R., Li, A., & Swift, J. (2014). Public voices in pharmaceutical deliberations: negotiating ‘clinical benefit’ in the FDA’s Avastin hearing. Journal Ofmedical Humanities, 35, 149–170. doi:10.1007/s10912-014-9277-5
- Timmermans, S., & Leiter, V. (2000). The redemption of thalidomide: Standardising the risk of birth defects. Social Studies of Science, 30, 41–71. doi:10.1177/030631200030001002
- Transvaginal Mesh Attorneys. (2013). Help for surgical mesh complications. Retrieved from http://www.youtube.com/watch?v=_k4SFWWvWYs
- Wagner, U. (2010). Risk in the application of medical devices: Human factors in the medical environment. Quality Management in Health Care, 19, 304–311. doi:10.1097/QMH.0b013e3181f9ee66
- Wittgenstein, L. (1953). Philosophical investigations. New York, NY: Macmillan.
- Zimmerman, R. (2011). Surgeons challenge FDA warnings on vaginal mesh. Commonhealth: Reformand Reality. Retrieved from http://commonhealth.wbur.org/2011/08/surgeons-challenge-fda-warnings-on-vaginal-mesh